[Retracted] Application Value of Combined Detection of Anti-<i>β</i>2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Groups</td><td class="align_center"><i>n</i></td><td class="align_center">Anti-<i>β</i>2-GPI (RU/ml<sup>−1</sup>)</td><td class="align_center">ACL (U/ml)</td><td class="align_center">LA ratio</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">Experimental group</td><td class="align_center">30</td><td class="align_center">25.99 ± 2.40</td><td class="align_center">44.13 ± 3.12</td><td class="align_center">1.86 ± 0.38</td></tr><tr><td class="align_left">Control group</td><td class="align_center">30</td><td class="align_center">3.92 ± 0.63</td><td class="align_center">4.03 ± 0.56</td><td class="align_center">1.04 ± 0.13</td></tr><tr><td class="align_left"><i>T</i></td><td class="align_center"> </td><td class="align_center">48.717</td><td class="align_center">68.734</td><td class="align_center">11.346</td></tr><tr><td class="align_left"><i>P</i></td><td class="align_center"> </td><td class="align_center">&lt;0.001</td><td class="align_center">&lt;0.001</td><td class="align_center">&lt;0.001</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of serum indexes (‾<i>x</i> ± <i>S</i>).</div>

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: [Retracted] Application Value of Combined Detection of Anti-<i>β</i>2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome 

Table 2 | [Retracted] Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome 